TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of voting result and Scrutinizer Report09-08-2023
09-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of voting result08-08-2023
Torrent Pharmaceuticals Results Earnings Call for Q1FY24
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.07-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2023
Audio Recording of Conference call with Analysts /Investors on Financial Results for the quarter ended 30th June, 2023 is attached07-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Nikhil Khattau as an Independent Director of the Company07-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Alteration of Articles of Association of the Company07-08-2023
Torrent Pharma Q1 net profit rises 7% at Rs 378 crore
Revenue for the first quarter of the current fiscal rose to Rs 2,591 crore as against Rs 2,347 crore in the year-ago period, Torrent Pharma said in a statement.07-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to reg 30 of SEBI(LODR), 2015 we would like to inform that Company has commenced commercial operations of its new Oral Oncology facility at Bileshwarpura close to Indrad, Gujarat. The facility will cater to all our markets. please take the information on record07-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of 50th Annual General meeting of the Company held on 07.08.202307-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to analyst on unaudited consolidated financial result for quarter ended 30.06.202307-08-2023